Canopy Growth Corporation (TSX: WEED) has announced this morning that the company has completed the first phase of their partnership with Spanish company Alcaliber SA. Canopy has successfully transferred 1,500 cannabis clones to Spain for cultivation.
Canopy has transferred the 1,500 cannabis clones to Alcaliber’s Spanish cultivation facility. Under the terms of the agreement, Canopy will sell its Tweed branded products around Europe, while Alcaliber will focus on producing a variety of cannabis genetics to supply the company. The partnership was entered into back in September 2o17.
Alcaliber SA is one of the leading pharmaceutical companies in Europe and produces 27% of the worlds morphine supply.
Canopy Growth Corporation continues its dominance of the Canadian public cannabis sector. This news marks the third continent that will plant its clones on.
You may be interested
Health Canada Issues Significant Changes to Industrial Hemp RegulationsEditor - August 11, 2018
Health Canada, the overseeing body in charge of industrial hemp licensing and its regulations has just issued a new class exemption for cultivators of the plant within…
CCT150 Top 5 Banking Solutions for the Cannabis and Hemp IndustriesEditor - August 10, 2018
Federally run banking institutions have been instructed to refrain from opening bank accounts with companies involved in the cannabis and hemp industries. If they do, they could…
Canopy Growth Corp. to Conduct Clinical Trials Using CBD to Treat Anxiety in AnimalsEditor - August 8, 2018
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and its wholly owned subsidiary Canopy Health Innovations Inc. has announced this morning that they been approved by the Veterinary Drug Directorate…